Request an appointmentat Mayo Clinic
Hepatic artery infusion pump chemotherapy shrinks liver tumors, giving more people a chance for surgery.
Dr. Rory Smoot explains what cholangiocarcinoma is and how the rare bile duct cancer is diagnosed and treated.
Research on adagrasib has demonstrated promising clinical activity in patients with gastrointestinal cancers that harbor KRAS G12C mutations.
Chemoradiation followed by liver transplant is being used more widely to treat perihilar cholangiocarcinoma, the most common form of bile duct cancer.
A team of researchers from the Mayo Clinic Cancer Center has been awarded a five-year, $11.5-million Specialized Program of Research Excellence (SPORE) grant in hepatobiliary ...